Latest Articles
FGFR2-responsive self-assembled hydrogel releases its inhibitor to suppress the progression of endometriosis.
Fibroblast growth factor receptor 2 (FGFR2) has emerged as a highly promising therapeutic target due to its critical role in the pathogenesis and progression of endometriosis. To date, a variety …
Published: May 9, 2026, midnight
Mankind Pharma Introduces Dydroboon 30mg Sustained Release Tablets for Treatment of Endometriosis - Medical Dialogues
Mankind Pharma Introduces Dydroboon 30mg Sustained Release Tablets for Treatment of Endometriosis Medical Dialogues
Published: March 5, 2024, 8 a.m.
A Novel Conductive Polypyrrole-Chitosan Hydrogel Containing Human Endometrial Mesenchymal Stem Cell-Derived Exosomes Facilitated Sustained Release for Cardiac Repair - Wiley Online Library
A Novel Conductive Polypyrrole-Chitosan Hydrogel Containing Human Endometrial Mesenchymal Stem Cell-Derived Exosomes Facilitated Sustained Release for Cardiac Repair Wiley Online Library
Published: Jan. 4, 2024, 8 a.m.
Link copied to clipboard!